Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...

While insulin resistance is an established risk factor for many chronic diseases, its drivers remain unclear. Here, extensive genetic mapping of Diversity Outbred in Australia (DOz) mice reveals the ...